VistaGen Therapeutics, Inc. Uncategorized Contracts & Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrant's Securities
VistaGen Therapeutics, Inc.
Biotechnology
NV
2024
Exclusive Negotiation Agreement by and between Fuji Pharma Co., Ltd. and Vistagen Therapeutics, Inc., dated September 1, 2023
VistaGen Therapeutics, Inc.
Biotechnology
CA
2023
Open Market Sale AgreementSM, dated May 14, 2021, by and between VistaGen Therapeutics, Inc. and Jefferies LLC
VistaGen Therapeutics, Inc.
Biotechnology
NY
2021
Option Agreement, by and between VistaGen Therapeutics, Inc. and Pherin Pharmaceuticals, Inc., dated September 11, 2018
VistaGen Therapeutics, Inc.
Biotechnology
CA
2018
EXCLUSIVE LICENSEAND SUBLICENSE AGREEMENT by andbetween VISTAGENTHERAPEUTICS, INC. and APOLLOBIOLOGICS LP EXCLUSIVE LICENSEAND SUBLICENSE AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
DE
2017
R E C I T A L S :
VistaGen Therapeutics, Inc.
Biotechnology
2016
VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc.
Biotechnology
NY
2016
ACKNOWLEDGEMENT AND AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
2015
AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
NY
2015
AMENDMENT NO. 2
VistaGen Therapeutics, Inc.
Biotechnology
2014
SUBSCRIPTIONAGREEMENT UNITS
VistaGen Therapeutics, Inc.
Biotechnology
2014
VISTAGEN THERAPEUTICS, INC.
VistaGen Therapeutics, Inc.
Biotechnology
NY
2014
ASSIGNMENTANDASSUMPTION AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
2013
NEGATIVE COVENANT AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
CA
2012
SIGN AND RETURN THIS PAGE TO CIRMRT1-01012-1 NOTICE OF GRANT AWARD CIRM RFA-08-02:Tools & Technologies California Institute for Regenerative Medicine
VistaGen Therapeutics, Inc.
Biotechnology
2011
Notice of Award
VistaGen Therapeutics, Inc.
Biotechnology
2011
VISTAGEN THERAPEUTICS, INC. CONVERSION AGREEMENT
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
CLINICAL STUDY AGREEMENT IND 75,807 AV-101
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
Shawn K. Singh, JD Chief Executive Officer VistaGen Therapeutics, Inc. 384 Oyster Point Blvd., No. 8 South San Francisco, CA 94080 ###-###-#### ***@***
VistaGen Therapeutics, Inc.
Biotechnology
2011
WITNESSETH:
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011
VISTAGEN THERAPEUTICS, INC.
VistaGen Therapeutics, Inc.
Biotechnology
CA
2011